Schedule 13G ownership disclosure

NASUS PHARMA LTD

Ordinary Shares · CUSIP: M7071P109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Dr. Ronnie Hershman

    Shares: 1,383,512.00 · Class: 15.3%

  • Hershman Holdings LLC

    Shares: 891,187.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-022144
Form type
SCHEDULE 13G
Filer
Hershman Ronnie
CIK
CIK 2086512
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub